On Being the Right Size: The Impact of Population Size and Stochastic Effects on the Evolution of Drug Resistance in Hospitals and the Community
暂无分享,去创建一个
[1] Pia Abel zur Wiesch,et al. Population biological principles of drug-resistance evolution in infectious diseases. , 2011, The Lancet. Infectious diseases.
[2] J. Townsend,et al. Retrospective evidence for a biological cost of vancomycin resistance determinants in the absence of glycopeptide selective pressures , 2011, The Journal of antimicrobial chemotherapy.
[3] L. Hsu,et al. Community-associated meticillin-resistant Staphylococcus aureus , 2010, The Lancet.
[4] F. DeLeo,et al. Community-associated meticillin-resistant Staphylococcus aureus , 2010, The Lancet.
[5] P. Böelle,et al. Antibiotic Dose Impact on Resistance Selection in the Community: a Mathematical Model of β-Lactams and Streptococcus pneumoniae Dynamics , 2010, Antimicrobial Agents and Chemotherapy.
[6] Henry F. Chambers,et al. Waves of resistance: Staphylococcus aureus in the antibiotic era , 2009, Nature Reviews Microbiology.
[7] Andrew R. Francis,et al. The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis , 2009, Proceedings of the National Academy of Sciences.
[8] France Mentré,et al. Carriage of methicillin-resistant Staphylococcus aureus in home care settings: prevalence, duration, and transmission to household members. , 2009, Archives of internal medicine.
[9] A. Sousa,et al. Positive Epistasis Drives the Acquisition of Multidrug Resistance , 2009, PLoS genetics.
[10] R. Neumar,et al. A national analysis of the relationship between hospital factors and post-cardiac arrest mortality , 2009, Intensive Care Medicine.
[11] Bengt Åhgren. Is it better to be big? The reconfiguration of 21st century hospitals: responses to a hospital merger in Sweden. , 2008, Health policy.
[12] J. Chastre. Evolving problems with resistant pathogens. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[13] F. Daschner,et al. Antibiotic use in two cohorts of German intensive care units. , 2006, The Journal of hospital infection.
[14] P. Nordmann,et al. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[15] J. Vaqué,et al. Nosocomial and community-acquired meticillin-resistant Staphylococcus aureus infections in hospitalized patients (Spain, 1993-2003). , 2006, The Journal of hospital infection.
[16] A. Troelstra,et al. Extensive Hospital-Wide Spread of a Multidrug-Resistant Enterobacter cloacae Clone, with Late Detection Due to a Variable Antibiogram and Frequent Patient Transfer , 2006, Journal of Clinical Microbiology.
[17] A. Troelstra,et al. Antibiotic rotation and development of gram-negative antibiotic resistance. , 2005, American journal of respiratory and critical care medicine.
[18] David L. Smith,et al. Strategic interactions in multi-institutional epidemics of antibiotic resistance. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[19] H. Goossens,et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study , 2005, The Lancet.
[20] D. Zoutman,et al. The relationship between hospital infection surveillance and control activities and antibiotic-resistant pathogen rates. , 2005, American journal of infection control.
[21] Carl T. Bergstrom,et al. Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[22] Ronald N. Jones,et al. Relationships between patient- and institution-specific variables and decreased antimicrobial susceptibility of Gram-negative pathogens. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] J. Quinn,et al. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. , 2003, JAMA.
[24] D. Gillespie. Approximate accelerated stochastic simulation of chemically reacting systems , 2001 .
[25] O. Cars,et al. Variation in antibiotic use in the European Union , 2001, The Lancet.
[26] D. Mckillop,et al. Investigating productivity change and hospital size: a nonparametric frontier approach , 2000 .
[27] Alice N. Neely,et al. Survival of Enterococci and Staphylococci on Hospital Fabrics and Plastic , 2000, Journal of Clinical Microbiology.
[28] S Bonhoeffer,et al. Evaluating treatment protocols to prevent antibiotic resistance. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[29] D Draper,et al. Hospital characteristics and quality of care. , 1992, JAMA.
[30] D. Hartl,et al. Principles of population genetics , 1981 .
[31] D. Gillespie. A General Method for Numerically Simulating the Stochastic Time Evolution of Coupled Chemical Reactions , 1976 .
[32] R. Punnett,et al. The Genetical Theory of Natural Selection , 1930, Nature.